2-38989304-G-A

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2

The NM_005633.4(SOS1):​c.3357C>T​(p.Thr1119=) variant causes a synonymous change. The variant allele was found at a frequency of 0.0000654 in 1,604,444 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000061 ( 0 hom. )

Consequence

SOS1
NM_005633.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 5.02
Variant links:
Genes affected
SOS1 (HGNC:11187): (SOS Ras/Rac guanine nucleotide exchange factor 1) This gene encodes a protein that is a guanine nucleotide exchange factor for RAS proteins, membrane proteins that bind guanine nucleotides and participate in signal transduction pathways. GTP binding activates and GTP hydrolysis inactivates RAS proteins. The product of this gene may regulate RAS proteins by facilitating the exchange of GTP for GDP. Mutations in this gene are associated with gingival fibromatosis 1 and Noonan syndrome type 4. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP6
Variant 2-38989304-G-A is Benign according to our data. Variant chr2-38989304-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 45360.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-38989304-G-A is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd4 at 17 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SOS1NM_005633.4 linkuse as main transcriptc.3357C>T p.Thr1119= synonymous_variant 21/23 ENST00000402219.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SOS1ENST00000402219.8 linkuse as main transcriptc.3357C>T p.Thr1119= synonymous_variant 21/231 NM_005633.4 A1Q07889-1

Frequencies

GnomAD3 genomes
AF:
0.000112
AC:
17
AN:
151930
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000725
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000191
Gnomad OTH
AF:
0.000479
GnomAD3 exomes
AF:
0.0000639
AC:
16
AN:
250202
Hom.:
0
AF XY:
0.0000813
AC XY:
11
AN XY:
135262
show subpopulations
Gnomad AFR exome
AF:
0.0000617
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000115
Gnomad OTH exome
AF:
0.000165
GnomAD4 exome
AF:
0.0000606
AC:
88
AN:
1452514
Hom.:
0
Cov.:
27
AF XY:
0.0000650
AC XY:
47
AN XY:
723112
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000672
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000233
Gnomad4 FIN exome
AF:
0.0000187
Gnomad4 NFE exome
AF:
0.0000743
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.000112
AC:
17
AN:
151930
Hom.:
0
Cov.:
32
AF XY:
0.000108
AC XY:
8
AN XY:
74190
show subpopulations
Gnomad4 AFR
AF:
0.0000725
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000191
Gnomad4 OTH
AF:
0.000479
Alfa
AF:
0.000181
Hom.:
0
Bravo
AF:
0.000117
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.000110
EpiControl
AF:
0.00

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMay 23, 2016Variant summary: The SOS1 c.3357C>T (p.Thr1119Thr) variant causes a synonymous change involving a conserved nucleotide with 5/5 splice prediction tools predicting no significant effect on splicing and ESE finder predicting that this variant may create a new affect ESE site of, although these predictions have yet to be functionally assessed. This variant was observed in the large, broad control population, ExAC, with an allele frequency of 9/118630 (1/13175, frequency: 0.0000759), predominantly in the European (Non-Finnish) cohort, 8/65198 (1/8149), which significantly exceeds the estimated maximal expected allele frequency for a pathogenic SOS1 variant of 1/33333 (0.00003). Therefore, suggesting that the variant is a common polymorphism found in population(s) of European (Non-Finnish) origin. A publication cites the variant to have been found in at least one affected individual, although with limited information (ie lack of co-occurrence cosegregation data). In addition, a reputable clinical laboratory cites the variant as "likely benign." Therefore, taking all available lines of evidence into consideration, the variant of interest is classified as Benign. -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineOct 16, 2015p.Thr1119Thr in exon 21 of SOS1: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. It has been identified in 8/65198 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitut e.org; dbSNP rs373319212). -
Noonan syndrome 4 Benign:1
Likely benign, criteria provided, single submitterclinical testingGenome-Nilou Lab-- -
Noonan syndrome 4;C4551558:Fibromatosis, gingival, 1 Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsAug 20, 2021- -
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsMar 09, 2020This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Fibromatosis, gingival, 1 Benign:1
Likely benign, criteria provided, single submitterclinical testingGenome-Nilou Lab-- -
RASopathy Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 11, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.33
CADD
Benign
8.8
DANN
Benign
0.77
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.27
Details are displayed if max score is > 0.2
DS_AL_spliceai
0.27
Position offset: 10

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs373319212; hg19: chr2-39216445; API